-
Innovation at BD
The Future and InnovationDiscover how we’re innovating to drive better outcomes for patients at critical moments throughout their lives
-
NEWS
BD Receives FDA 510(k) Clearance for EnCor EnCompass™ Breast Biopsy and Tissue Removal SystemState-of-the-art, multi-modality breast biopsy system slated to be in the market in early 2026 FRANKLIN LAKES, N.J., Jan. 15, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a...
-
NEWS
BD Names Shawn Bevec as Senior Vice President of Investor RelationsBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Shawn Bevec has been named senior vice president of investor relations, effective...
-
News
Patterns of Bacterial ResistanceListen as BD thought leaders Dr. Gupta and Dr. Yu give insights into patterns of rising bacterial resistance at a Health Watch USA Meeting on May 19, 2022